Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
06 Janvier 2021 - 4:00PM
Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today announced
that Jigar Raythatha, CEO, will present a company overview at
the J.P. Morgan Healthcare Conference at 10:50 AM
EST on Thursday, January 14, 2021. A live audio webcast
of the presentation and archive for replay will be available on the
Investor Relations section of Constellation’s website
at http://ir.constellationpharma.com/events-and-presentations/events.
The audio webcast replay will be available for 30 days following
the live presentation.
About Constellation Pharmaceuticals
Constellation Pharmaceuticals is a clinical-stage
biopharmaceutical company developing novel therapeutics that
selectively modulate gene expression to address serious unmet
medical needs in patients with cancer. The Company has a deep
understanding of how epigenetic and chromatin modifications in
cancer cells and in the tumor and immune microenvironment play a
fundamental role in driving disease progression and drug
resistance. Constellation is driving development of the BET
inhibitor CPI-0610 for the treatment of myelofibrosis as well as
the EZH2 inhibitor CPI-0209 for the treatment of solid
tumors. The Company is also applying its broad research and
development capabilities to explore other novel targets that
directly and indirectly impact gene expression to fuel a
sustainable pipeline of innovative small-molecule product
candidates.
Contacts
Kia Khaleghpour, Ph.D.Vice President, Investor
Relations and CommunicationsConstellation Pharmaceuticals+1
617-844-6859kia.khaleghpour@constellationpharma.com
Lauren ArnoldMedia RelationsMacDougall Biomedical
Communications+1 781-235-3060larnold@macbiocom.com
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Constellation Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur